Biomarkers in community-acquired pneumonia: a state-of-the-art review.

Link to article at PubMed

Related Articles

Biomarkers in community-acquired pneumonia: a state-of-the-art review.

Clinics (Sao Paulo). 2012 Nov;67(11):1321-5

Authors: Seligman R, Ramos-Lima LF, Oliveira Vdo A, Sanvicente C, Pacheco EF, Dalla Rosa K

Abstract
Community-acquired pneumonia (CAP) exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for searching for antibiotic therapy modifications and for CAP diagnosis, prognosis and follow-up treatment. This non-systematic state-of-the-art review presents the biological and clinical features of biomarkers in CAP patients, including procalcitonin, C-reactive protein, copeptin, pro-ANP (atrial natriuretic peptide), adrenomedullin, cortisol and D-dimers.

PMID: 23184211 [PubMed - indexed for MEDLINE]

Leave a Reply

Your email address will not be published.